Nanoform secures €5 million R&D loan from Business Finland to advance clinical development of nanoapalutamide
Nanoform Finland Plc (Nanoform), a leading nanoparticle medicine performance-enhancing company, announced that Business Finland has approved a €5 million research and development loan to support the clinical development of nanoapalutamide, Nanoform’s …